Related Experiment Video
Updated: May 29, 2026

Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
A methodological perspective on genetic risk prediction studies in type 2 diabetes: recommendations for future
Sara M Willems1, Raluca Mihaescu, Eric J G Sijbrands
1Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands. s.m.willems@erasmusmc.nl
Abstract:
Fueled by the successes of genome-wide association studies, numerous studies have investigated the predictive ability of genetic risk models in type 2 diabetes. In this paper, we review these studies from a methodological perspective, focusing on the variables included in the risk models as well as the study designs and populations investigated. We argue and show that differences in study design and characteristics of the study population have an impact on the observed predictive ability of risk models. This observation emphasizes that genetic risk prediction studies should be conducted in those populations in which the prediction models will ultimately be applied, if proven useful. Of all genetic risk prediction studies to date, only a few were conducted in populations that might be relevant for targeting preventive interventions.
Related Concept Videos
Type II Diabetes I: Introduction
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
